A fractionalorder model for optimizing combination therapy in heterogeneous lung cancer integrating immunotherapy and targeted therapy to minimize side effects

D AmiloChinedu IzuchukwuK SadriHao-Ren YaoE HincalY Shehu2024-09-162024-09-16WOShttps://hdl.handle.net/10539/40839A fractionalorder model for optimizing combination therapy in heterogeneous lung cancer integrating immunotherapy and targeted therapy to minimize side effectsJournal Article